Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.35 - $0.72 $41,671 - $85,723
-119,061 Reduced 83.77%
23,059 $8,000
Q4 2022

Feb 14, 2023

BUY
$0.32 - $8.27 $45,478 - $1.18 Million
142,120 New
142,120 $55,000
Q4 2021

Feb 15, 2022

SELL
$1.66 - $2.64 $20,044 - $31,878
-12,075 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$2.58 - $3.36 $24,350 - $31,711
-9,438 Reduced 43.87%
12,075 $33,000
Q2 2021

Aug 16, 2021

BUY
$2.7 - $3.81 $26,273 - $37,075
9,731 Added 82.59%
21,513 $71,000
Q1 2021

May 18, 2021

SELL
$3.02 - $5.16 $189,190 - $323,253
-62,646 Reduced 84.17%
11,782 $39,000
Q4 2020

Feb 17, 2021

BUY
$2.66 - $4.18 $197,978 - $311,109
74,428 New
74,428 $282,000
Q3 2019

Nov 14, 2019

SELL
$2.74 - $4.65 $87,019 - $147,679
-31,759 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$2.66 - $6.28 $84,478 - $199,446
31,759 New
31,759 $117,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $22.1M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.